Millennium Management’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $567K | Buy |
407,858
+256,622
| +170% | +$357K | ﹤0.01% | 3305 |
|
|
2025
Q1 | $149K | Sell |
151,236
-19,723
| -12% | -$19.4K | ﹤0.01% | 3691 |
|
|
2024
Q4 | $224K | Buy |
170,959
+67,638
| +65% | +$88.6K | ﹤0.01% | 3626 |
|
|
2024
Q3 | $355K | Sell |
103,321
-146,154
| -59% | -$503K | ﹤0.01% | 3487 |
|
|
2024
Q2 | $823K | Buy |
249,475
+80,610
| +48% | +$266K | ﹤0.01% | 2965 |
|
|
2024
Q1 | $795K | Sell |
168,865
-13,232
| -7% | -$62.3K | ﹤0.01% | 3090 |
|
|
2023
Q4 | $1.33M | Buy |
182,097
+159,410
| +703% | +$1.16M | ﹤0.01% | 2673 |
|
|
2023
Q3 | $274K | Sell |
22,687
-106,461
| -82% | -$1.29M | ﹤0.01% | 3507 |
|
|
2023
Q2 | $1.37M | Sell |
129,148
-300,722
| -70% | -$3.18M | ﹤0.01% | 2739 |
|
|
2023
Q1 | $4.23M | Sell |
429,870
-175,417
| -29% | -$1.73M | ﹤0.01% | 2040 |
|
|
2022
Q4 | $8.9M | Buy |
605,287
+357,966
| +145% | +$5.27M | ﹤0.01% | 1674 |
|
|
2022
Q3 | $3M | Buy |
247,321
+163,126
| +194% | +$1.98M | ﹤0.01% | 2589 |
|
|
2022
Q2 | $1.18M | Sell |
84,195
-135,959
| -62% | -$1.9M | ﹤0.01% | 3302 |
|
|
2022
Q1 | $3.14M | Sell |
220,154
-110,672
| -33% | -$1.58M | ﹤0.01% | 2714 |
|
|
2021
Q4 | $6.98M | Buy |
330,826
+159,365
| +93% | +$3.36M | ﹤0.01% | 1937 |
|
|
2021
Q3 | $4.5M | Buy |
171,461
+148,876
| +659% | +$3.91M | ﹤0.01% | 2278 |
|
|
2021
Q2 | $704K | Buy |
+22,585
| New | +$704K | ﹤0.01% | 3950 |
|
|
2021
Q1 | – | Sell |
-95,018
| Closed | -$3.26M | – | 4848 |
|
|
2020
Q4 | $3.26M | Sell |
95,018
-94,627
| -50% | -$3.25M | ﹤0.01% | 2199 |
|
|
2020
Q3 | $5.84K | Sell |
189,645
-33,599
| -15% | -$1.03K | 0.01% | 1307 |
|
|
2020
Q2 | $6.93M | Buy |
+223,244
| New | +$6.93M | 0.01% | 1171 |
|